Obatala's Chief Operations Officer, David Bode, spoke during a New Orleans City Council Meeting on October 19 in favor of providing a permanent funding mechanism for the New Orleans BioDistrict. On October 20, Obatala's CEO, Dr. Trivia Frazier, co-wrote an Op-Ed with the CEO of AxoSim, Dr. Lowry Curley, that supported the signing of the Cooperative Endeavor Agreement that would provide a mechanism for funding and managing the BioDistrict that can further the Biotech industry in New Orleans. The City Council voted to execute the CEA on October 20, paving the way for the diversification of the New Orleans economy and the growth of the Life Sciences community.